New Delhi [India], November 19: Medicamen Organics Limited (MOL) (NSE- MEDIORG) one of the prominent players in the pharmaceutical sector specializing in the development, manufacturing, and distribution of an extensive range of pharmaceutical dosages has announced its Unaudited H1 FY25 resul